David Pass

Chief Executive Officer at

Altrixbio, Inc.

58 year

Health Technology

Consumer Services

Profile

David Pass is President & Chief Executive Officer at Altrixbio, Inc. since 2025 and Director at Gelesis Srl.
Former roles include Director-Marketing at Bristol-Myers Squibb Pharma Co. from 1994 to 2002, Vice President-Marketing at Johnson & Johnson from 2002 to 2008, Vice President-Marketing at Boehringer Ingelheim Corp.
from 2009 to 2016, Chief Operating & Commercial Officer at Gelesis, Inc. from 2016 to 2023, and Chief Operating & Commercial Officer at Gelesis Holdings, Inc. from 2022 to 2023.
Education includes undergraduate and doctorate degrees from Philadelphia College of Pharmacy.

David Pass active positions

Companies	Position	Start
Gelesis Srl Gelesis Srl BiotechnologyHealth Technology Develops novel category of potential therapies for GI-related chronic diseases	Director/Board Member	-
Altrixbio, Inc. Altrixbio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs that targeting metabolic diseases and type 2 diabetes	Chief Executive Officer	16/09/2025

All active positions of David Pass

Former positions of David Pass

Companies	Position	End
GELESIS HOLDINGS, INC.	Chief Operating Officer	30/10/2023
GELESIS INC	Chief Operating Officer	01/10/2023
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products	Sales & Marketing	01/08/2016
JOHNSON & JOHNSON	Sales & Marketing	01/01/2008
Bristol-Myers Squibb Pharma Co.	Sales & Marketing	01/07/2002

See the detail of David Pass's experience

Training of David Pass

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of David Pass's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	8
Johnson & Johnson Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products	Health Technology
Gelesis, Inc. Gelesis, Inc. BiotechnologyHealth Technology Operates as biotechnology company which develops novel category of therapies for GI-related chronic diseases	Health Technology
Boehringer Ingelheim Corp. Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets health care products	Health Technology
Bristol-Myers Squibb Pharma Co.
Philadelphia College of Pharmacy Philadelphia College of Pharmacy Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gelesis Srl Gelesis Srl BiotechnologyHealth Technology Develops novel category of potential therapies for GI-related chronic diseases	Health Technology
Altrixbio, Inc. Altrixbio, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs that targeting metabolic diseases and type 2 diabetes	Health Technology
Gelesis Holdings, Inc. Gelesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops superabsorbent hydrogel therapeutics for chronic gastrointestinal, weight management and diabetes	Health Technology

See company connections